Full text is available at the source.
Abstract
Population-level data on blood pressure control among users of glucagon-like peptide 1 receptor agonists (GLP-1 RAs) with hypertension is limited.
- Hypertension is a significant factor contributing to cardiovascular issues in the United States.
- GLP-1 receptor agonists are commonly used to treat type 2 diabetes and obesity.
- There is a lack of comprehensive studies on the effectiveness of GLP-1 RAs for controlling blood pressure in hypertensive patients.
Simplified